Healthpoint Biotherapeutics today announced that it has acquired Regranex® Gel, along with the corresponding intellectual property (including patents), from Systagenix. Terms of the deal were not disclosed.
|
Thu, 06/09/2011
|
||
|
Wed, 06/08/2011
Healthpoint Biotherapeutics today announced that Travis E. Baugh, President and Chief Operating Officer, and Robert Bancroft, Executive Vice President, Strategic and Commercial Development, will present an overview of the Company, its commercial products and its R&D pipeline at two upcoming investment conferences: Jefferies 2011 Global Healthcare Conference and the 2011 Wells Fargo Securities Healthcare Conference. |
||
|
Wed, 05/11/2011
Healthpoint Biotherapeutics today announced the introduction of OASIS® Ultra Tri-Layer Matrix, a natural extracellular matrix (ECM) material derived from three layers of porcine small intestinal submucosa (SIS). The three-layer construct of ECM was designed to incorporate increased structure into difficult-to-heal and chronic wounds. |
||
Wed, 04/20/2011
The Wound Institute today announced the launch of a new online resource for patients and their caregivers offering disease state education to empower them in managing difficult-to-heal and chronic wounds. The new online site will initially offer three educational modules, available in either English or Spanish language versions: 1) Sores That Will Not Heal; 2) Debridement of Sores (debridement refers to the removal of dead tissue to prepare a wound for healing); and 3) Treatment of Sores. The educational resources are made available at no cost to patients and caregivers, and can be accessed at www.TheWoundInstitute.com. |
||
Thu, 04/14/2011
The Wound Institute today announced that it will feature a multidisciplinary forum on dynamic reciprocity at the combined meeting of the Symposium on Advanced Wound Care (SAWC) and the Wound Healing Society (WHS) being held in Dallas at the Gaylord Texan Hotel & |
